Author:
Baptiste Janelle V.,Barta Julie,Patel Sahil,Thomson Carey C.,Tukey Melissa,Michaud Gaetane
Publisher
Springer International Publishing
Reference95 articles.
1. National Lung Screening Trial Research Team, Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ. The National Lung Screening Trial: overview and study design. Radiology. 2011;258(1):243–53. https://doi.org/10.1148/radiol.10091808. Epub 2010 Nov 2. PMID: 21045183; PMCID: PMC3009383.
2. Armstrong K, Kim JJ, Halm EA, Ballard RM, Schnall MD. Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs. Cancer. 2016;122(9):1338–42. https://doi.org/10.1002/cncr.29937. Epub 2016 Feb 29. PMID: 26929386; PMCID: PMC4840047.
3. Wood DE, Eapen GA, Ettinger DS, et al. NCCN clinical practice guidelines in oncology: lung cancer screening. Version 1, 2012. http://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf. Accessed 9 Jan 2012.
4. Moyer VA, U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330–8. https://doi.org/10.7326/M13-2771. PMID: 24378917.
5. US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Kubik M, Landefeld CS, Li L, Ogedegbe G, Owens DK, Pbert L, Silverstein M, Stevermer J, Tseng CW, Wong JB. Screening for lung cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(10):962–70. https://doi.org/10.1001/jama.2021.1117. PMID: 33687470.